Pamela F. Schwartz

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

Paul M. Ridker, James H. Revkin, Pierre Amarenco et al. · New England Journal of Medicine · 2017 · 623 citations · Full text

Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab

Paul M. Ridker, Jean‐Claude Tardif, Pierre Amarenco et al. · New England Journal of Medicine · 2017 · 355 citations · Full text

Evaluation of prognostic factors in the surgical treatment of adrenal gland tumors in dogs: 41 cases (1999–2005)

Pamela F. Schwartz, Janet R. Kovak, Alexandra Koprowski et al. · Journal of the American Veterinary Medical Association · 2008 · 109 citations · Full text

A Prospective, Randomized, Masked, and Placebo-Controlled Efficacy Study of Intraarticular Allogeneic Adipose Stem Cells for the Treatment of Osteoarthritis in Dogs

Robert J. Harman, Kim Carlson, Jamie S. Gaynor et al. · Frontiers in Veterinary Science · 2016 · 99 citations · Full text

Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials

Paul M. Ridker, Pierre Amarenco, Robert Brunell et al. · American Heart Journal · 2016 · 64 citations · Full text